These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2237422)

  • 1. FDA gets Kessler; NIH gets left out.
    Culliton BJ
    Science; 1990 Nov; 250(4982):749. PubMed ID: 2237422
    [No Abstract]   [Full Text] [Related]  

  • 2. Kessler stays, Healy goes.
    Gershon D; Mervis J
    Nature; 1993 Mar; 362(6415):3. PubMed ID: 8446168
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA's Kessler stays, NIH's Healy goes.
    Greenberg DS
    Lancet; 1993 Mar; 341(8846):681-2. PubMed ID: 8095583
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA not NIH can speed new drugs.
    Miller HI
    Nature; 2011 Apr; 472(7342):169. PubMed ID: 21490657
    [No Abstract]   [Full Text] [Related]  

  • 5. U.S. science policy. Cancer institute director tapped for FDA.
    Kaiser J; Couzin J
    Science; 2006 Mar; 311(5768):1692. PubMed ID: 16556808
    [No Abstract]   [Full Text] [Related]  

  • 6. U.S. biomedical policy. Acting FDA head drops NCI post.
    Kaiser J
    Science; 2005 Oct; 310(5745):29. PubMed ID: 16210502
    [No Abstract]   [Full Text] [Related]  

  • 7. U.S. biomedical policy. NCI head to fill in at FDA after Crawford resignation.
    Couzin J; Kaiser J
    Science; 2005 Sep; 309(5744):2142-3. PubMed ID: 16195428
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA upgrade proposed.
    Gershon D
    Nature; 1991 May; 351(6324):258. PubMed ID: 1851962
    [No Abstract]   [Full Text] [Related]  

  • 9. Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice.
    Fed Regist; 1998 Jun; 63(105):30002-5. PubMed ID: 10180274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bernadine Healy bows out.
    Cohen J
    Science; 1993 Mar; 259(5100):1388-9. PubMed ID: 8451631
    [No Abstract]   [Full Text] [Related]  

  • 11. 2006 people to watch. Double trouble?
    Science; 2006 Jan; 311(5757):35. PubMed ID: 16400129
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer chief embraces top drugs job.
    Wadman M
    Nature; 2005 Sep; 437(7059):606. PubMed ID: 16193009
    [No Abstract]   [Full Text] [Related]  

  • 13. Experts trying to repair split in health bureaucracy.
    Zoler ML
    Med World News; 1989 Feb; 30(3):77. PubMed ID: 10294488
    [No Abstract]   [Full Text] [Related]  

  • 14. APHIS, FDA, and NIH issue memorandum of understanding on laboratory animal welfare.
    Shalev M
    Lab Anim (NY); 2006 Apr; 35(4):13. PubMed ID: 16582888
    [No Abstract]   [Full Text] [Related]  

  • 15. In need of rehab.
    Nature; 2005 Oct; 437(7060):789-90. PubMed ID: 16208322
    [No Abstract]   [Full Text] [Related]  

  • 16. Reviewing new, very complicated drugs.
    Goldsmith MF
    JAMA; 1985 Oct; 254(16):2215-6, 2218, 2221. PubMed ID: 4046145
    [No Abstract]   [Full Text] [Related]  

  • 17. Wrong committees axed?
    Miller HI
    Nature; 1994 Jun; 369(6483):701. PubMed ID: 8008058
    [No Abstract]   [Full Text] [Related]  

  • 18. Budgets up at NIH, NCI, and FDA.
    Cancer Discov; 2014 Mar; 4(3):263. PubMed ID: 24596185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough of the year. Breakdowns of 2001.
    Science; 2001 Dec; 294(5551):2446. PubMed ID: 11752541
    [No Abstract]   [Full Text] [Related]  

  • 20. The path to personalized medicine.
    Hamburg MA; Collins FS
    N Engl J Med; 2010 Jul; 363(4):301-4. PubMed ID: 20551152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.